Close Menu

More articles about Point-of-Care Testing

The firm said that its lateral flow test may enable sports teams and paramedics to quickly decide whether there's a concussion or not.

The proposed acquisitions follows two deals last month by PreCheck and is aimed at strengthening its point-of-care screening capabilities.

The firm said that it is developing an over-the-counter diagnostic technology to detect mosquito-borne illnesses in minutes instead of days.

The Tokyo-based firm said it will use the funding to support prototyping and commercialization of its mass spectrometry and optical spectroscopy instruments.

MyCartis said that the new company, Antelope Dx, is developing a home test to diagnose Chlamydia trachomatis and Neisseria gonorrhea.

The drug developer said that the biomarker panel will form the basis of a planned point-of-care test for acute respiratory distress syndrome.

MX3 Diagnostics' saliva test conducts electrochemical measurements of the ionic density of saliva to enable a quick response to dehydration concerns.

Trinity Biotech said that the decline in point-of-care revenues reflects lower sales in its two key geographic markets, Africa and the US.

The partners plan to validate the accuracy, effectiveness, and clinical implications of Group K's MultiNostic liver function test, which is pending FDA clearance.

Beyond its HostDx Sepsis test, the firm is working on a test to detect and differentiate bacterial from viral infections in patients presenting with fever.

The two companies will work together to bring the point-of-care pretreatment diagnostic based on the XDX-01 biomarker to market in 2020.

The firm said its platform provides sample-to-answer results for two of the most frequently tested sexually transmitted infections, enabling rapid testing and treatment.

At the Henry Ford Health System in Southeast Michigan, bringing on the Roche Cobas Liat for flu testing led to a season of headaches before it started paying off.

The point-of-care diagnostics firm tallied $9.6 million in revenues in the second quarter, besting analysts' consensus estimate of $8.8 million.

The firm said revenues fell because of delayed shipments of HIV self-tests and ongoing softness in the consumer genomics markets.

Expedeon will supply Sona Nanotech with colloidal gold technology for use in the development of multiplex lateral flow assays.

The German firm has developed a PCR technology that rapidly regulates temperature with so-called microcyclers diffused in the master mix solution.

Formerly known as Diassess, the Emeryville, California-based startup will use the funding to finance regulatory clearances and early commercialization.

In US influenza testing, providers see growth in placements within hospital emergency departments, physicians' offices, urgent care centers, and retail clinics.

The company also received a contract from the Henry M. Jackson Foundation for a separate sepsis test.

Pages